Synbias Pharma AG (Synbias-Gemini Group) is a Swiss-headquartered pharmaceutical company specializing in the development and manufacturing of highly potent Active Pharmaceutical Ingredients (APIs), primarily used in cancer therapies including anthracyclines and nucleosides. The production facility Gemini PharmChem is located in Mannheim, Germany. The company holds 30-50% global market share for particular oncology APIs and ships to 21 countries. The group has passed 17 regulatory inspections including FDA, ANVISA, and German cGMP.
highly potent oncology APIs, anthracycline manufacturing, nucleoside APIs, synthesis route development, high-purity API production
2 sites worldwide
No reviews available yet.
No documents available.